Investment Focus
Pappas Ventures is an active, involved investor. We seek teams with which we can build true partnerships.
The strength of Pappas Ventures lies in our clear vision and singular focus. We invest exclusively in the life sciences sector – biotechnology, biopharmaceuticals, drug delivery, medical devices and related ventures. Because of our singleminded focus, we know how to connect the dots along the uncertain pathway that life sciences companies must travel in their pursuit of success. Our longstanding relationships throughout the industry, for example, enable us to help our portfolio companies find just the right talent for their management teams. Our deep understanding of the drug development process yields valuable insight and guidance that our management teams can use in crafting clinical and regulatory strategies. Our ties to other respected venture investors can lead to additional capital to fund the future growth of our portfolio companies.
Unlike many of our VC brethren, we invest a substantial portion (about half) of our capital in early-stage companies that have yet to begin testing their products in clinical trials. We invest the other half in companies whose lead products are at the Phase 1 or Phase 2 stage of development.
From the very beginning we’ve invested on a national basis, deploying about a third of our capital in California, and an equal amount in important biotech hotspots along the East Coast (including our home territory, the Research Triangle area of North Carolina). What further differentiates us, however, is that we have an equally long record of investing in under-served regions – such as Texas, Indiana, Montreal – that have outstanding centers of medical research, but which don’t attract a commensurate share of venture capital. We continue to see these under-served markets as an important, and growing, opportunity.